Drug-Related Side Effects and Adverse Reactions
"Drug-Related Side Effects and Adverse Reactions" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Disorders that result from the intended use of PHARMACEUTICAL PREPARATIONS. Included in this heading are a broad variety of chemically-induced adverse conditions due to toxicity, DRUG INTERACTIONS, and metabolic effects of pharmaceuticals.
Descriptor ID |
D064420
|
MeSH Number(s) |
C25.100
|
Concept/Terms |
Drug-Related Side Effects and Adverse Reactions- Drug-Related Side Effects and Adverse Reactions
- Drug Related Side Effects and Adverse Reactions
- Side Effects of Drugs
- Drug Side Effects
- Drug Side Effect
- Effects, Drug Side
- Side Effect, Drug
- Side Effects, Drug
- Adverse Drug Reaction
- Adverse Drug Reactions
- Drug Reaction, Adverse
- Drug Reactions, Adverse
- Reactions, Adverse Drug
- Adverse Drug Event
- Adverse Drug Events
- Drug Event, Adverse
- Drug Events, Adverse
Drug Toxicity- Drug Toxicity
- Toxicity, Drug
- Drug Toxicities
- Toxicities, Drug
|
Below are MeSH descriptors whose meaning is more general than "Drug-Related Side Effects and Adverse Reactions".
Below are MeSH descriptors whose meaning is more specific than "Drug-Related Side Effects and Adverse Reactions".
This graph shows the total number of publications written about "Drug-Related Side Effects and Adverse Reactions" by people in this website by year, and whether "Drug-Related Side Effects and Adverse Reactions" was a major or minor topic of these publications.
View timeline visualization
Year | Major Topic | Minor Topic | Total |
---|
1995 | 3 | 2 | 5 |
1996 | 2 | 2 | 4 |
1997 | 2 | 0 | 2 |
1998 | 0 | 1 | 1 |
1999 | 2 | 3 | 5 |
2000 | 2 | 1 | 3 |
2001 | 2 | 0 | 2 |
2002 | 1 | 4 | 5 |
2003 | 6 | 2 | 8 |
2004 | 1 | 1 | 2 |
2005 | 7 | 4 | 11 |
2006 | 9 | 17 | 26 |
2007 | 13 | 14 | 27 |
2008 | 10 | 9 | 19 |
2009 | 19 | 27 | 46 |
2010 | 10 | 27 | 37 |
2011 | 17 | 19 | 36 |
2012 | 19 | 19 | 38 |
2013 | 27 | 22 | 49 |
2014 | 20 | 14 | 34 |
2015 | 17 | 16 | 33 |
2016 | 21 | 19 | 40 |
2017 | 31 | 20 | 51 |
2018 | 28 | 23 | 51 |
2019 | 30 | 17 | 47 |
2020 | 34 | 7 | 41 |
2021 | 26 | 11 | 37 |
2022 | 22 | 1 | 23 |
2023 | 21 | 1 | 22 |
2024 | 9 | 11 | 20 |
2025 | 0 | 1 | 1 |
Below are the most recent publications written about "Drug-Related Side Effects and Adverse Reactions" by people in Profiles.
-
Artificial intelligence-enabled safety monitoring in Alzheimer's disease clinical trials. J Prev Alzheimers Dis. 2025 Jan; 12(1):100002.
-
Physician-Patient Communication about Novel Drugs and High-Risk Medical Devices. Med Decis Making. 2025 02; 45(2):156-167.
-
NCCN Guidelines® Insights: Management of Immunotherapy-Related Toxicities, Version 2.2024. J Natl Compr Canc Netw. 2024 Nov; 22(9):582-592.
-
A machine learning technology for addressing medication-related risk in older, multimorbid patients. Am J Manag Care. 2024 Aug 01; 30(8):e233-e239.
-
Overall side effect assessment of oxaliplatin toxicity in rectal cancer patients in NRG oncology/NSABP R04. Qual Life Res. 2024 Nov; 33(11):3069-3079.
-
High-risk medication use among older adults with cognitive impairment living alone in the United States. J Am Geriatr Soc. 2024 Dec; 72(12):3719-3729.
-
Top 10 Signs and Symptoms of Psychotropic Adverse Drug Events to Monitor in Residents of Long-Term Care Facilities. J Am Med Dir Assoc. 2024 Sep; 25(9):105118.
-
Mitigating time toxicity in lymphoma and multiple myeloma. Leuk Lymphoma. 2024 Oct; 65(10):1418-1429.
-
Preclinical side effect prediction through pathway engineering of protein interaction network models. CPT Pharmacometrics Syst Pharmacol. 2024 Jul; 13(7):1180-1200.
-
Phenotyping Hepatic Immune-Related Adverse Events in the Setting of Immune Checkpoint Inhibitor Therapy. JCO Clin Cancer Inform. 2024 05; 8:e2300159.